Dont hesitate to ask who will be administering the injection and what their qualifications are
Injectable GHK-Cu protocols typically use 1-2 mg daily subcutaneously, with visible results appearing at 12-16 weeks and optimal outcomes at 6+ months
What compounds are in the Klow Stack, and why are they grouped together for research
Proposed Mechanisms DSIP appears to work through multiple pathways: it may affect GABA-A receptors, the same inhibitory pathways targeted by common sleep medications
If the peptide restrictions are reversed through formal FDA rulemaking, compounding pharmacies would be legally allowed to prepare those peptides, but only as traditional, patient-specific compounded drugs, not as mass-market or FDA-approved therapies. If the peptides are formally added to the 503A bulk list, he says, pharmacies would have to follow the traditional 503A compounding rules
The safety profile of the combination reflects the individual safety profiles of each component